Medicare Enrolled

Dr. Colin Gillespie, M.D.

Pulmonary Disease · Cleveland, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
9500 EUCLID AVE # M2-141, Cleveland, OH 44195
2164442674
In practice since 2006 (19 years)
NPI: 1487716437 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gillespie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gillespie? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gillespie

Dr. Colin Gillespie is a pulmonary disease specialist in Cleveland, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gillespie performed 337 Medicare services across 310 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gillespie received a total of $67,476 from 24 pharmaceutical and/or device companies across 182 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gillespie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 337 Medicare services $67,476 industry payments

Medicare Practice Summary

Medicare Utilization ↗
337
Medicare services
Bottom 27% in OH for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
310
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
49 $4 $1,045
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
48 $80 $1,298
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
45 $75 $419
Chest fluid aspiration with imaging guidance
This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement.
31 $86 $1,202
Endoscopic needle biopsy of windpipe, airway, or lung
A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung.
24 $105 $1,397
Bronchoscopy with ultrasound and lymph node sampling
A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes.
24 $171 $1,833
Additional lung lobe biopsy via endoscope
This procedure involves taking a tissue sample from an additional lobe of the lung using an endoscope, performed after an initial biopsy.
23 $38 $374
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $46 $270
Computer-assisted navigation of lung airways
This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation.
21 $73 $726
Bronchoscopy with ultrasound and lymph node sampling
A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes.
20 $139 $1,657
Bronchoscopy with ultrasound and growth treatment
A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found.
16 $51 $508
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $102 $730
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$67,476
Total received (2018-2024)
Avg $9,639/year across 7 years
Top 6% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
182
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$37,231 (55.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,240 (22.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,005 (22.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,064
2023
$11,048
2022
$9,139
2021
$1,645
2020
$1,802
2019
$19,017
2018
$21,761

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$1,917
Noah Medical Corporation
$485
Olympus America Inc.
$162
Boston Scientific Corporation
$122
Philips North America LLC
$97
Body Vision Medical Inc.
$90
Medtronic, Inc.
$71
Galvanize Therapeutics, Inc
$60
Pulmonx Corporation
$59
Top 3 companies account for 83.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$23,470
Intuitive Surgical, Inc.
$11,019
BOSTON SCIENTIFIC CORPORATION
$10,294
Cook Incorporated
$5,589
Auris Health, Inc.
$4,062
Pulmonx Corporation
$2,639
INTUITIVE SURGICAL, INC.
$1,917
Noah Medical Corporation
$1,863
Ethicon Inc.
$1,708
Covidien LP
$1,420
Cook Medical LLC
$1,198
Bard Peripheral Vascular, Inc.
$820
Becton, Dickinson and Company
$393
Body Vision Medical Inc.
$302
Olympus America Inc.
$162
CoapTech, Inc.
$148
Bard Access Systems, Inc.
$114
Philips North America LLC
$97
Medtronic, Inc.
$92
ERBE USA Inc
$61
Galvanize Therapeutics, Inc
$60
Merck Sharp & Dohme LLC
$19
ICU Medical Inc
$16
Ambu Inc.
$13
Top 3 companies account for 66.4% of all-time payments
Associated products mentioned in payments ›
(BI2) IGT Systems Undivided · ACQUIRE · ALAIR · ALAIR BRONCHIAL THERMOPLASTY SYSTEM · ALIYA SYSTEM · Acquire · BLUE RHINO · CHARTIS CATHETER · COOK MEDICAL CENTESIS & DRAINAGE · COOK MEDICAL CIAGLIA BLUE RHINO · Cook Medical Percutaneous Tracheostomy · Da Vinci Surgical System · EXPECT · Erbe VIO APC CRYO · GALAXY · GENERAL PULMONARY · GENERAL PULMONARY · GENERAL THERAPIES · GENERAL PULMONARY · GENERAL THERAPIES · ILLUMISITE · ION · LungVision · MONARCH · Monarch · Monarch Platform · PUMA-G System · Percutaneous trach tube insertion kit · Pulmonx Endobronchial Valve EBV · SHILEY · Single-Use flexible Video Bronchoscope · SpyGlass Discover · SuperDimension · THERAPIES · Wayne · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA · superDimension · trach tubes and tracheostomy tubes.
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for pulmonary disease in OH.

Looking for a pulmonary disease specialist in Cleveland?
Compare pulmonary diseases in the Cleveland area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gillespie is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 6% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gillespie experienced with bronchial irrigation and suction for cell collection?
Based on Medicare claims data, Dr. Gillespie performed 49 bronchial irrigation and suction for cell collection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gillespie receive payments from pharmaceutical companies?
Yes. Dr. Gillespie received a total of $67,476 from 24 companies across 182 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gillespie's costs compare to other pulmonary diseases in Cleveland?
Dr. Gillespie's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gillespie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →